- Home
- OGI vs PYXS Comparison
OGI vs PYXS Comparison
Compare OGI & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | PYXS |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.5M | 243.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OGI | PYXS |
|---|---|---|
| Price | $1.79 | $1.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | ★ 1.7M | 1.7M |
| Earning Date | 12-16-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $186,075,713.00 | $2,820,000.00 |
| Revenue This Year | $20.38 | N/A |
| Revenue Next Year | $6.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $0.83 |
| 52 Week High | $2.24 | $5.55 |
Technical Indicators
Market Signals| Indicator | OGI | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.13 | 20.83 |
| Support Level | $1.60 | $1.05 |
| Resistance Level | $2.24 | $4.58 |
| Average True Range (ATR) | 0.18 | 0.30 |
| MACD | -0.00 | -0.36 |
| Stochastic Oscillator | 42.00 | 2.11 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.